Brief: Humacyte Announces Presentation Of Positive Results From V007 Phase 3 Av Access Clinical Trial At The American Society Of Nephrology’S Kidney Week 2024
28/10/2024 11:51
Oct 28 (Reuters) - Humacyte Inc HUMA.O :
* HUMACYTE ANNOUNCES PRESENTATION OF POSITIVE RESULTS FROM
V007
PHASE 3 AV ACCESS CLINICAL TRIAL AT THE AMERICAN SOCIETY OF
NEPHROLOGY’S KIDNEY WEEK 2024
Source text: ID:nGNX2KFVtg
Further company coverage: HUMA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary